HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ -- Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, "Diagens"), a pioneer in medical imaging foundation models, today announced its first annual results since its listing. The report marks a pivotal milestone in the company's...
Hence then, the article about diagens annual results 100b parameter model reshapes medical ai landscape licensing revenue becomes primary growth engine was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine )
Also on site :
- Meta looks to report fastest revenue growth since 2021
- Meta’s AI Is Delivering but Comes With a Hefty Price Tag .. PYMNTS.com
- Microsoft, Meta, and Google just announced billions more in AI spending. Only Google convinced investors it’s paying off